108 related articles for article (PubMed ID: 30720011)
1. [Adherence to chronic polytherapy in secondary prevention of myocardial infarction: limits and perspectives.].
Di Martino M; Lallo A; Davoli M; Fusco D
Recenti Prog Med; 2019 Jan; 110(1):7-9. PubMed ID: 30720011
[TBL] [Abstract][Full Text] [Related]
2. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
3. Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design.
Di Martino M; Alagna M; Cappai G; Mataloni F; Lallo A; Perucci CA; Davoli M; Fusco D
BMJ Open; 2016 Apr; 6(4):e010926. PubMed ID: 27044584
[TBL] [Abstract][Full Text] [Related]
4. The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction.
Di Martino M; Kirchmayer U; Agabiti N; Bauleo L; Fusco D; Perucci CA; Davoli M
BMJ Open; 2015 Jun; 5(6):e007866. PubMed ID: 26063569
[TBL] [Abstract][Full Text] [Related]
5. [Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction].
Perrone E; Lenzi J; Avaldi VM; Castaldini I; Protonotari A; Rucci P; Piccinni C; Morini M; Fantini MP
Epidemiol Prev; 2015; 39(2):106-14. PubMed ID: 26036739
[TBL] [Abstract][Full Text] [Related]
6. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
7. Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care.
Kasteleyn MJ; Wezendonk A; Vos RC; Numans ME; Jansen H; Rutten GE
Fam Pract; 2014 Dec; 31(6):688-93. PubMed ID: 25106412
[TBL] [Abstract][Full Text] [Related]
8. Self-controlled case-series study to verify the effect of adherence to Beta-blockers in secondary prevention of myocardial infarction.
Di Bartolomeo S; Marino M; Guastaroba P; Valent F; De Palma R
J Am Heart Assoc; 2015 Jan; 4(1):e001575. PubMed ID: 25567050
[TBL] [Abstract][Full Text] [Related]
9. In-hospital myocardial infarction and adherence to evidence-based drug therapies: a real-world evaluation.
Soldati S; Di Martino M; Castagno D; Davoli M; Fusco D
BMJ Open; 2021 Feb; 11(2):e042878. PubMed ID: 33550255
[TBL] [Abstract][Full Text] [Related]
10. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
[TBL] [Abstract][Full Text] [Related]
11. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study.
Lindhardsen J; Ahlehoff O; Gislason GH; Madsen OR; Olesen JB; Torp-Pedersen C; Hansen PR
Ann Rheum Dis; 2012 Sep; 71(9):1496-501. PubMed ID: 22402144
[TBL] [Abstract][Full Text] [Related]
12. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V;
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818
[TBL] [Abstract][Full Text] [Related]
13. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
Buja A; Boemo DG; Furlan P; Bertoncello C; Casale P; Baldovin T; Marcolongo A; Baldo V
Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
[TBL] [Abstract][Full Text] [Related]
14. [Methodology and rules for measuring adherence: beyond the doctor-patient combination.].
Alagna M; Di Martino M
Recenti Prog Med; 2021 Sep; 112(9):557-560. PubMed ID: 34392318
[TBL] [Abstract][Full Text] [Related]
15. Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy.
Kirchmayer U; Agabiti N; Belleudi V; Davoli M; Fusco D; Stafoggia M; Arcà M; Barone AP; Perucci CA
J Clin Pharm Ther; 2012 Feb; 37(1):37-44. PubMed ID: 21294760
[TBL] [Abstract][Full Text] [Related]
16. The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility.
Khatib R; Patel N; Hall AS
BMC Cardiovasc Disord; 2020 Feb; 20(1):46. PubMed ID: 32013880
[TBL] [Abstract][Full Text] [Related]
17. Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.
Urbinati S; Olivari Z; Gonzini L; Savonitto S; Farina R; Del Pinto M; Valbusa A; Fantini G; Mazzoni A; Maggioni AP;
Eur J Prev Cardiol; 2015 Dec; 22(12):1548-56. PubMed ID: 25452625
[TBL] [Abstract][Full Text] [Related]
18. Medication Adherence In Post Myocardial Infarction Patients.
Hussain S; Jamal SZ; Qadir F
J Ayub Med Coll Abbottabad; 2018; 30(4):552-557. PubMed ID: 30632336
[TBL] [Abstract][Full Text] [Related]
19. Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction.
Doll JA; Hellkamp AS; Goyal A; Sutton NR; Peterson ED; Wang TY
JAMA Cardiol; 2016 Oct; 1(7):787-794. PubMed ID: 27541822
[TBL] [Abstract][Full Text] [Related]
20. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
Mathews R; Wang W; Kaltenbach LA; Thomas L; Shah RU; Ali M; Peterson ED; Wang TY
Circulation; 2018 May; 137(20):2128-2138. PubMed ID: 29386204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
